Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
1 other identifier
interventional
160
1 country
1
Brief Summary
This study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Written Exposure Therapy for PTSD and delivered in an accelerated (i.e., 5-day) group treatment format, preceded and followed by individual treatment sessions. 160 participants will be randomized into one of two study conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2025
CompletedFirst Posted
Study publicly available on registry
July 16, 2025
CompletedStudy Start
First participant enrolled
December 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
December 3, 2025
December 1, 2025
3 years
July 7, 2025
December 1, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Posttraumatic Stress Disorder Checklist (PCL-5)
Self-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5. Total scores range from 0-80 (higher scores indicate greater PTSD severity).
Change from baseline through 3 and 6 month follow-up assessment
Insomnia Severity Index (ISI)
The ISI assesses perceived severity of insomnia. Total scores range from 0-28 (higher scores indicate greater insomnia severity).
Change from baseline through 3 and 6 month follow up
Nightmare Disorders Index
The NDI is a self-report assessment of nightmare disorder.
Change from baseline through 3 and 6 month assessments
Secondary Outcomes (7)
Clinician Administered PTSD Scale (CAPS-5)
Change from baseline to 1-month follow-up assessment
Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)
Change from baseline to 1-month follow-up assessment
Generalized Anxiety Disorder Screener (GAD-7)
Change from baseline through 3 and 6 month follow-up assessment
Trauma-Related Nightmare Survey (TRNS)
Change from baseline through 3 and 6 month follow-up assessment
Depressive Symptoms Index-Suicidality Subscale (DSI-SS)
Change from baseline through 3 and 6 month follow up assessment
- +2 more secondary outcomes
Other Outcomes (8)
Neuropsychological battery
Change from second baseline to 1-month follow-up assessment
Split Week Self-Assessment of Sleep Survey (SASS-Y)
Change from baseline through 3 and 6 month follow up assessments
Sleep Diary and Nightmare Log
Change from second baseline through to the end of treatment
- +5 more other outcomes
Study Arms (2)
Written exposure therapy and sleep hygiene for insomnia and nightmares
ACTIVE COMPARATORWritten exposure therapy and CBT for insomnia and nightmares
EXPERIMENTALInterventions
CBTi focuses on stimulus control, eliminating maladaptive coping habits, reducing arousal, and challenging maladaptive thoughts about sleep in an effort to reduce time to fall asleep and time awake during the night.
CBTn involves writing about a distressing or frequent nightmare, rewriting the narrative of the nightmare to target trauma-related themes, and reading the rescripted nightmare narrative.
WET is a trauma-focused intervention in which individuals write about their worst traumatic experience following scripted instruction from the therapist.
Involves reviewing sleep diary data, sleep education, and reviewing and discussing sleep hygiene practices.
Eligibility Criteria
You may qualify if:
- Defense Enrollment Eligibility Reporting System (DEERS) eligible active-duty military personnel or veteran, 18-65 years old.
- Ability to speak and read English.
- Clinically significant PTSD symptoms (CAPS-5 \> 25 with at least one Intrusion symptom and at least one Avoidance symptom).
- Clinically significant symptoms of insomnia disorder (Structured Clinical Interview for Sleep Disturbance DSM-5 (SCISD) Insomnia Criteria are met and Insomnia Severity Index (ISI) \> 11).
- Nightmares \> 1 monthly (as reported on the SCISD).
- Willing to refrain from new behavioral health or medication treatment for issues pertaining to PTSD, sleep, and nightmares during study participation.
You may not qualify if:
- Current suicide or homicide risk meriting crisis intervention.
- Inability to comprehend the baseline screening questionnaires.
- Unwilling to remain abstinent from alcohol during therapy sessions.
- Serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders warranting immediate clinical attention based on interviewer assessment and clinical judgement.
- Currently engaged in evidence-based psychotherapy for PTSD (e.g., Prolonged Exposure Therapy, Cognitive Processing Therapy, Written Exposure Therapy) or insomnia or nightmares (e.g., Cognitive Behavioral Therapy for Insomnia or Nightmares).
- Pregnancy, as determined by self-report, because pregnancy can adversely affect sleep outside of PTSD, insomnia, and nightmares.
- Working duty shifts ending later than 21:00 or starting before 05:30 more than 2 times per month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Arizonacollaborator
- NDRI-USA, Inc.collaborator
- Palo Alto Veterans Institute for Researchlead
- The University of Texas Health Science Center at San Antoniocollaborator
Study Sites (1)
Fort Hood
Kileen, Texas, 76544, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychologist
Study Record Dates
First Submitted
July 7, 2025
First Posted
July 16, 2025
Study Start
December 2, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
December 3, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
The data used to conduct these analyses are stored in the STRONG STAR Repository. Deidentified data can be accessed by emailing repository@strongstar.org